MBL

Anti-Podoplanin (Human) mAb

Product Code:
 
MBL-D320-3
Product Group:
 
Primary Antibodies
Supplier:
 
MBL
Host Type:
 
Rat
Antibody Isotype:
 
IgG2a κ
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
NZ-1.2
Regulatory Status:
 
RUO
Target Species:
 
Human
Applications:
  • Flow Cytometry
  • Immunohistochemistry (IHC)
  • Immunoprecipitation (IP)
  • Western Blot (WB)
Shipping:
 
4°C
Storage:
 
-20°C
1 / 4
2 / 4
3 / 4
4 / 4
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
MBL-D320-3100 ul£328.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Applications:
WB - 0.1-1 μg/mL IP - 0.5-1 μg/200 μL of cell extract from 1x106 cells FCM - 0.1 μg/mL (final concentration) IHC - 0.25-1 μg/mL
Background:
Podoplanin is a sialoglycoprotein, which can be used to distinguish lymphatic vessels from blood vessels. Podoplanin is also known as Aggrus, a platelet aggregation-inducing factor. Furthermore, podoplanin has been reported to be a novel cancer stem cell marker. This rat monoclonal antibody against human podoplanin is useful for immunohistochemistry with formalin-fixed paraffin embedded sections. This antibody also can be used in FACS, Western-blot, and immunoprecipitation.
Formulation:
PBS/50% glycerol, pH 7.2
Gene IDs:
Human: 10630 Mouse: 14726
Source:
Purified IgG from hybridoma supernatant
Target:
PDPN

Documents

References

1) Kaji, C., et al., Acta. Histochem. Cytochem. in press 2) Kato, Y., et al., Biochem. Biophys. Res. Commun. 349, 1301-1307 (2006) 3) Kaneko, M. K., et al., FEBS Lett. 581, 331-336 (2007) 4) Kato, Y., et al., Cancer. Sci. 99, 54-61 (2008) 5) Ogasawara, S., et al., Hybridoma 27, 259-267 (2008) 6) Kato, Y., et al., Nucl. Med. Biol. 37, 785-794 (2010)